Health News Archive - February 23, 2010
TAMPA, Fla., Feb.
QUEBEC CITY, Feb. 23 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.
BOSTON, Feb. 23 /PRNewswire/ -- Summer Street Research Partners is pleased to announce the recent closing of a financing for Novadaq Technologies, a company that develops and markets real-time fluorescence imaging technology products for use in the operating room.
FRAZER, Pa. and MALVERN, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has exercised its option to acquire Ception Therapeutics, Inc., following receipt of positive data from a clinical study in adults with eosinophilic asthma.
SOUTH SAN FRANCISCO, Calif., Feb. 23 /PRNewswire/ -- iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced the appointment of Michael C.
CORAL GABLES, Fla., Feb. 23 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (NasdaqCM: CPRX) announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S.
With Congress deadlocked and Republicans digging in their heels, President Barack Obama has his work cut out for him as he announced his plan to revamp the US healthcare system on Monday.
NEWTON, Mass., Feb. 23 /PRNewswire/ -- Microfluidics International Corporation (OTC Bulletin Board: MFLU), today reported unaudited financial results for the fourth quarter and year-ended December 31, 2009.
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.